NDC11 42961025501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 42961-0255-01 | 42961-0255 |
| 42961-0255-1 | 42961-0255 |
| 42961-255-01 | 42961-255 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xpect Industrial Eye Relief | GLYCERIN, NAPHAZOLINE HCL | Cintas Corporation | a0167d06-7adb-36f4-e053-2a95a90af9ef | 2025-09-30 | Warnings | 42961-255-01 42961-255 42961025501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.